Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders

Tan, May Loong; Ho, Jacqueline J; Teh, Keng Hwang

doi:10.1002/14651858.cd009398.pub2

Cited by 14 publications

(13 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar results were presented by Bailey et al who reported an improvement in health and health maintenance as the crucial motivation for DS use in the US population [18]. To upgrade health was also the important reason for DS use in the Korean population [9].…”

Section: Motives For Ds Administrationsupporting

confidence: 87%

See 1 more Smart Citation

Dietary supplements: a great menace of our time or golden remedy? A cross-sectional study among school-aged children

Krawiec

Chądzyńska

Raciborski

et al. 2019

pdia

View full text Add to dashboard Cite

A b s t r a c t Introduction: Dietary supplements (DS) are commonly used as a remedy for various health issues as they are widely advertised and available. Aim: This study aimed to evaluate the prevalence of DS use among school-aged children in Warsaw, the capital city of Poland. Additionally, we evaluated the parents' motivations for DS administration, the frequency of the use of specific compounds and the influence of child's history of allergy on DS use. Material and methods: Children aged 6-7 years who attended the first grade of primary schools in Warsaw were included into the study. Forty-two out of 170 primary schools in Warsaw were randomly selected of which 38 agreed to participate. The research tool was a self-administered questionnaire. Results: Half of the studied children received DS in the previous 6 months. Fatty acids were the most commonly administered DS (49.8%). The most common reason for administering DS was prevention of diseases (69.1%). The total household income correlated positively with the DS use. History of food allergy was one of the factors which increased the risk of DS use, whereas diagnosis of asthma did not correlate with a higher frequency of DS use. Conclusions: This study shows the need to educate patients about medical indications for DS use and expected benefits in the specific indications.

show abstract

Section: Motives For Ds Administrationsupporting

confidence: 87%

“…Despite the popularity of DS consumption, the scientific evidence does not confirm their expected effectiveness [7][8][9][10][11].…”

Section: Introductionmentioning

confidence: 99%

Dietary supplements: a great menace of our time or golden remedy? A cross-sectional study among school-aged children

Krawiec

Chądzyńska

Raciborski

et al. 2019

pdia

View full text Add to dashboard Cite

show abstract

“…However, most modern, western-type diets are seriously lacking in the long-chain omega-3 fatty acids [eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] that are most important for physical and mental wellbeing. Deficiencies in these omega-3s have been repeatedly implicated in ADHD and related child behaviour and learning difficulties (Richardson, 2006), and some evidence suggests benefits from supplementation with omega-3 fatty acids not only in these domains (Bloch and Qawasmi, 2011; Tan et al , 2012), but also for behaviour and cognition in children from the general school population (Richardson et al , 2012). Furthermore, very low blood levels of EPA and DHA were found in a recent study of healthy UK schoolchildren (Montgomery et al , 2013).…”

Section: Introductionmentioning

confidence: 99%

Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study – a randomized controlled trial

Montgomery

Burton

Sewell

et al. 2014

Journal of Sleep Research

View full text Add to dashboard Cite

Sleep problems in children are associated with poor health, behavioural and cognitive problems, as are deficiencies of long-chain omega-3 fatty acids such as docosahexaenoic acid. Theory and some evidence support a role for these fatty acids in sleep regulation, but this issue has received little formal investigation. We examined associations between blood fatty acid concentrations (from fingerstick blood samples) and subjective sleep (using an age-standardized parent questionnaire) in a large epidemiological sample of healthy children aged 7–9 years (n = 395) from mainstream UK schools. In a randomized controlled trial, we then explored whether 16-week supplementation (600 mg day−1) with algal docosahexaenoic acid versus placebo might improve sleep in a subset of those children (n = 362) who were underperforming in reading. In a randomly selected subsample (n = 43), sleep was also assessed objectively via actigraphy. In 40% of the epidemiological sample, Child Sleep Habits Questionnaire scores indicated clinical-level sleep problems. Furthermore, poorer total sleep disturbance scores were associated weakly but significantly with lower blood docosahexaenoic acid (std coeff. −0.105*) and a lower docosahexaenoic acid : arachidonic acid ratio (std coeff. −0.119**). The treatment trial showed no significant effects on subjective sleep measures. However, in the small actigraphy subsample, docosahexaenoic acid supplementation led on average to seven fewer wake episodes and 58 min more sleep per night. Cautiously, we conclude that higher blood levels of docosahexaenoic acid may relate to better child sleep, as rated by parents. Exploratory pilot objective evidence from actigraphy suggests that docosahexaenoic acid supplementation may improve children's sleep, but further investigations are needed.

show abstract

“…However, a Cochrane review reported that there is still no clear evidence to determine whether PUFAs are helpful for ADHD [29]. Recently, another Cochrane review reported that the intake of PUFAs improves the learning ability of children with learning disorder [30]. Also, in a recent 20-year study of young adults in the United States, it was reported that more intake of PUFAs is associated with lower prevalence rate of asthma [31].…”

Section: Intake Of Pufas For Chidrenmentioning

confidence: 99%

Polyunsaturated Fatty Acids in Children

Lee

2013

Pediatr Gastroenterol Hepatol Nutr

View full text Add to dashboard Cite

Polyunsaturated fatty acids (PUFAs) are the major components of brain and retina, and are the essential fatty acids with important physiologically active functions. Thus, PUFAs should be provided to children, and are very important in the brain growth and development for fetuses, newborn infants, and children. Omega-3 fatty acids decrease coronary artery disease and improve blood flow. PUFAs have been known to have anti-inflammatory action and improved the chronic inflammation such as auto-immune diseases or degenerative neurologic diseases. PUFAs are used for metabolic syndrome related with obesity or diabetes. However, there are several considerations related with intake of PUFAs. Obsession with the intake of unsaturated fatty acids could bring about the shortage of essential fatty acids that are crucial for our body, weaken the immune system, and increase the risk of heart disease, arrhythmia, and stroke. In this review, we discuss types, physiologic mechanism of action of PUFAs, intake of PUFAs for children, recommended intake of PUFAs, and considerations for the intake of PUFAs.

show abstract

Polyunsaturated fatty acids (PUFAs) for children with specific learning disorders

Cited by 14 publications

References 49 publications

Dietary supplements: a great menace of our time or golden remedy? A cross-sectional study among school-aged children

Dietary supplements: a great menace of our time or golden remedy? A cross-sectional study among school-aged children

Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study – a randomized controlled trial

Polyunsaturated Fatty Acids in Children

Contact Info

Product

Resources

About